✦ LIBER ✦

Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia

✍ Scribed by M. Christ-Crain; T. Breidthardt; D. Stolz; K. Zobrist; R. Bingisser; D. Miedinger; J. Leuppi; M. Tamm; B. Mueller; C. Mueller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B-type natriuretic peptide for risk stra

✍ C. Mueller; K. Laule-Kilian; A. Scholer; A. P. Perruchoud 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

The influence of clinical risk factors o

✍ B. M. Biccard; G. A. Lurati Buse; C. Burkhart; B. H. Cuthbertson; M. Filipovic; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Meta-analysis: proton pump inhibitor use

✍ J. JOHNSTONE; K. NERENBERG; M. LOEB 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

The risk factors for mortality of commun

✍ Rei Fujiki; Tomotaka Kawayama; Toshihiko Ueyama; Masao Ichiki; Hisamichi Aizawa 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 247 KB

Procalcitonin guidance for reduction of

✍ WEI LONG; XINGQI DENG; YU ZHANG; GANG LU; JUAN XIE; JIANGUO TANG 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

Use of Nesiritide (Human B-Type Natriure

✍ J. M. Simsic; V. S. Reddy; K. R. Kanter; P. M. Kirshbom; J. M. Forbess 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 87 KB